About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Voluntary Withdrawal from OTCQX
December 3, 2018
Click here to read more
Post navigation
Previous Post
Receipt of R&D Tax Incentive
Next Post
Phosphagenics and Mylan Agree Settlement
Related Posts
Appendix 4E and 2016 Annual Financial Report
February 28, 2017
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
January 31, 2017
